ASCOOvjeren akaunt

@ASCO

Official account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Association tweets labeled .

Alexandria, VA
Vrijeme pridruživanja: veljača 2009.

Tweetovi

Blokirali ste korisnika/cu @ASCO

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ASCO

  1. Prikvačeni tweet
    4. velj

    ‼️ Breaking news ‼️ Our 2020 Clinical Cancer Advances report is out, detailing progress in from the past year

    Poništi
  2. prije 18 sati

    The is holding a hearing on overcoming pharmaceutical barriers. We’re tuning in live @ 2 PM

    Poništi
  3. prije 18 sati
    Poništi
  4. proslijedio/la je Tweet
    prije 20 sati

    The American Society of Clinical Oncology () released a position statement, “Block Grants in Medicaid

    Poništi
  5. prije 20 sati

    Oncologist and past president testified before the Michigan State Senate to support reforms to and step therapy to improve care for patients w cancer

    Poništi
  6. proslijedio/la je Tweet
    Poništi
  7. proslijedio/la je Tweet
    prije 21 sat
    Poništi
  8. proslijedio/la je Tweet

    At now, 's Caroline Schenkel discusses the study presented at which showed the Use of Broader Criteria for Enrollment Would **Double** Number of Eligible Patients w . 🔗

    Prikaži ovu nit
    Poništi
  9. prije 21 sat

    Today  testifies before the Illinois State Senate supporting coverage for pts w . Take action w him by using our ACT Network to contact your representatives ➡️

    Poništi
  10. proslijedio/la je Tweet

    Proud to have been a part of this incredible collaborative effort led by and others. So much incredible progress made in the past year and so much more yet to come.

    Poništi
  11. proslijedio/la je Tweet
    prije 21 sat
    Poništi
  12. prije 22 sata

    We’re watching a Cmt hearing on “ in America: E-Cigarette Manufacturers' Impact on Public Health,” where the top makers are expected to testify. Tune in @ 10:30 AM

    Poništi
  13. proslijedio/la je Tweet
    prije 22 sata

    TODAY is the last day for advance registration rates for the Multidisciplinary Head and Neck Cancers Symposium! Join us for this practical and interactive meeting for the entire head and neck cancer care community!

    Poništi
  14. proslijedio/la je Tweet
    4. velj

    - ’s 2020 Clinical Cancer Advances report spotlights refinement in as the Advance of the Year. Read about how has changed & what that means for patients.

    Poništi
  15. proslijedio/la je Tweet

    Our Fellowship graduate, Dr. Omid Etemadi, helped bring integrative cancer care to his community in the Philippines and has been Executive Director of CancerCare Cancer Supportive Care Philippines for the last 8 years!

    Poništi
  16. proslijedio/la je Tweet
    4. velj

    Among others, great to see these highlighted areas for research priorities: - Reduce Adverse Consequences of Cancer Treatment - Reduce Obesity’s Impact on Cancer Incidence and Outcomes - Optimize Care for Older Adults With Cancer

    Poništi
  17. proslijedio/la je Tweet
    5. velj
    Poništi
  18. proslijedio/la je Tweet
    5. velj

    "What will each one of us around the globe do to keep pushing for changes and evidence that will help us reduce the incidence and burden of cancer?"

    Poništi
  19. proslijedio/la je Tweet
    5. velj

    Following significant progress made in the development of novel systemic therapies for patients with , the role of surgery in oncology continues to evolve, causing to select the refinement of surgical treatment of cancer as Advance of the Year

    Poništi
  20. proslijedio/la je Tweet
    Odgovor korisnicima i sljedećem broju korisnika:

    Honored to be an featured voice again this year for ! I’m looking forward to a great meeting and to sharing updates on new breakthroughs in cancer .

    Poništi
  21. prije 23 sata

    The Clinical Immuno-Oncology Symposium starts tomorrow! 📱 Follow our Featured Voices and join the discussion using    cc

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·